Immunotherapy in Combination With Chemoradiotherapy in Unresectable Locally Advanced Esophageal Cancer
Clinical trial NCT06173986 · RECRUITING
Trial details
- NCT number
- NCT06173986
- Sponsor
- Shanghai Chest Hospital
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-10
- Primary completion
- 2025-12-30
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.